The RELIAMPI brand, founded in 2014 (Sweden), from 585 sister brands and 17478 competing brands. RELIAMPI is owned by ASTRAZENECA, listed on the stock exchange of London Its International Securities Identification Number (ISIN) is GB0009895292. The sector of RELIAMPI is Drug Manufacturers.